Preclinical Data for Amyloid-Beta Precursor Protein (APP) siRNA in Cerebral Amyloid Angiopathy (CAA) Presented at the International Stroke Conference (ISC), 2025

Preclinical Data for Amyloid-Beta Precursor Protein (APP) siRNA in Cerebral Amyloid Angiopathy (CAA) Presented at the International Stroke Conference (ISC), 2025

Therapeutic rationale for APP-lowering siRNA and preclinical results from rodent models of CAA were presented at the International Stroke Conference (ISC), February 5-7, 2025, Los Angeles, United States.

Brown, et al. “Targeting Cerebral Amyloid Angiopathy at its Source: An Amyloid-beta Precursor Protein-Targeted siRNA Reduced Vascular Amyloid-beta and Hemorrhage in Rodent Models”